Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 5, 2007, Pages 321-326

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cobalamin; Creatinine; Folate; Homocysteine; Memory complaints; Mild cognitive impairment; Vascular disease

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BRAIN; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PRIORITY JOURNAL; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AGING; BRAIN; COGNITION DISORDERS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; REFERENCE VALUES; VASCULAR DISEASES;

EID: 34247328566     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100927     Document Type: Article

References (33)

1. Clarke R, Grimley Evans J, Schneede J, Nexö E, Bates C, Fletcher A, Prentice A, Johnston C, Ueland PM, Refsum H, Sherliker P, Birks J, Whitlock G, Breeze E, Scott JM: Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33: 34-41.
2. Troen A, Rosenberg I: Homocysteine and cognitive function. Semin Vasc Med 2005; 5: 209-214.
3. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Dement Geriatr Cogn Disord 2006: 22: 358-366.
4. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients. Dement Geriatr Cogn Disord 2005; 20: 35-41.
5. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine and vascular disease in elderly patients with psychogeriatric disease. Dement Geriatr Cogn Disord 2006; 21: 148-154.
6. Nilsson K, Gustafson L, Hultberg B: Relation between plasma homocysteine and Alzheimer's disease. Dement Geriatr Cogn Disord 2002; 14: 7-12.
7. Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattström L, Lindgren A, Israelsson B, Hultberg B: Hyperhomocysteinemia - a common finding in a psychogeriatric population. Eur J Clin Invest 1996; 26: 853-859.
8. Refsum H, Smith DA, Ueland PM, Nexö E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50: 3-32.
9. Refsum H, Ueland PM, Nygård O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
10. Nygard O, Vollset SE, Refsum H, Brattström L, Ueland PM: Plasma homocysteine and cardiovascular disease. J Intern Med 1999; 246: 425-454.
11. Mudd SH, Levy HL and Skovby F: Disorders of transsulfuration; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1995, pp 1279-1327.
12. Bottiglieri T: Folate, vitamin B-12 and neuropsychiatric disorders. Nutr Rev 1996; 54: 382-390.
13. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamins and folates in a psychogeriatric population. Dementia 1999; 10: 476-482.
14. Nilsson K, Gustafson L, Hultberg B: Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients. Scand J Clin Lab Invest 2002; 62: 385-390.
15. Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottigieri T: Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology 2005; 65: 1402-1408.
16. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U: Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 2005; 43: 1096-1100.
17. Lautenschlager NT, Flicker L, Vasikaran S, Leedman P, Almeida OP: Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry 2005; 13: 731-734.
18. Annerbo S, Wahlund LO, Lokk J: The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2005; 20: 209-214.
19. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Rio ID, Trabucchi M, Padovani A: Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry 2006; 21: 550-555.
20. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
21. DeCarli C: Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2003; 2: 15-21.
22. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili J, Scheltens P, Vellas B, Touchon J: Mild cognitive impairment in medical practice: critical review of the concept and new diagnostic procedures - report of the MCI working group of the European Consortium on Alzheimer's disease (EADC). J Neurol Neurosurg Psychiatry 2006; 77: 714-718.
23. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamins and folates in a psychogeriatric population. Dementia 1999; 10: 476-482.
24. Nilsson K, Gustafson L, Fäldt R, Andersson A, Hultberg B: Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Europ J Clin Invest 1994; 24: 600-606.
25. Andersson A, Isaksson A, Brattström L, Hultberg B: Homocysteine and other thiols determined in plasma by HPLC and thiolspecific postcolumn derivatization. Clin Chem 1993; 39: 1590-1597.
26. Johnston N, Jernberg T, Lindahl B, Lindbäck J, Stridsberg M, Larsson A, Venge P, Wallentin L: Biochemical indicators of cardiac and renal function in a healthy population. Clin Biochem 2004; 37: 210-216.
27. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
28. Feldman HH, Jacova C: Mild cognitive impairment. Am J Geriatr Psychiatry 2005; 13: 645-655.
29. Levy R: Age-associated cognitive decline. Int Psychogeriatr 1994; 6: 63-68.
30. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56: 37-42.
31. Norlund L, Grubb A, Fex G, Leksell H, Nilsson J-E, Schenk H, Hultberg B: The increase of plasma homocysteine concentration with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998; 36: 175-178.
32. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third national health and nutrition examination survey. Am J Clin Nutr 2001; 73: 927-933.
33. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD: Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 2005; 58: 847-857.